SESEN BIO INC (SESN) Stock Income Statement
USA - NASDAQ:SESN - US8177631053 - Common Stock
0.6288 USD
+0.04 (+7.29%)
0.5832 USD
-0.05 (-7.25%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 60.00M | 26.54M | 11.24M | 0.00 | 0.00 | |||
| Operating Expenses | 30.21M | -2.13M | 32.31M | 108.49M | 34.50M | |||
| Research and Development | 49.44M | 25.31M | 29.19M | 24.66M | 14.08M | |||
| Selling, General, and Administrative Expenses | 50.28M | 29.39M | 14.30M | 12.21M | 11.62M | |||
| Operating Income | 29.79M | 28.68M | -21.08M | -108.49M | -34.50M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Income/Expense | 880.00K | -60.00K | 130.00K | 990.00K | 810.00K | |||
| Non Recurring Items | N/A | -37.23M | N/A | N/A | N/A | |||
| Income Before Taxes | -8.05M | -8.61M | -20.95M | -107.50M | -33.69M | |||
| Income Tax | -3.88M | -8.27M | 1.45M | N/A | 0.00 | |||
| Net Income | -4.17M | -336.00K | -22.54M | -107.50M | -33.69M | |||
| EBITDA | N/A | 28.76M | -20.96M | -108.27M | -34.29M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.00 | -0.19 | -1.18 | -0.55 | |||
| Non GAAP EPS | -1.16 | -0.10 | -0.23 | -1.20 | -0.54 | |||
| Statistics | ||||||||
| Profit Margin | -6.96% | -1.27% | -200.53% | N/A | N/A | |||
| Operating Profit Margin | 49.65% | 108.04% | -187.54% | N/A | N/A | |||
All data in USD